spacer
home > epc > autumn 2008 > market epowers
PUBLICATIONS
European Pharmaceutical Contractor

Market ePowers

The biopharmaceutical industry is ideally situated to take advantage of the power of electronic marketing. Pharma companies will reap the rewards of developing highly effective, robust and scaleable electronic marketing programmes designed to meet today’s challenges.

These hurdles include:

  • Escalating competition for innovation
  • Promotion of new drugs or other products as soon as they are out of R&D
  • The rapid spread of globalisation requiring immediate international marketing efforts
  • Continually changing regulatory mandates that necessitate nimble response
  • Growing pressure to demonstrate financial performance despite finite or shrinking budgets

Whether a biotech or pharma business is in start-up mode, building demand or working toward an exit strategy, electronic marketing can play a central role in educating the worldwide market about pharmaceutical breakthroughs, establishing brand awareness, driving qualified leads, creating customer loyalty and increasing company valuation.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
5
     

There are no comments in regards to this article.

spacer
With more than 17 years of communications experience, Margaret Osborn brings clients a wealth of brand development, strategic planning, and traditional and electronic marketing expertise. As Vice President of Synergy Marketing Group Inc, based in Indianapolis, Indiana, she specialises in marketing for high-tech, scientific and industrial B2B firms, including global companies in the life sciences, healthcare, biotechnology and pharmaceutical sectors.
spacer
Margaret Osborn
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

The Importance of Critical Temperatures in the Freeze Drying of Pharmaceutical Products

Biopharma Group

Every formulation has a critical temperature, below which it should be cooled for complete solidification and maintained below during primary drying in order to prevent processing defects. To design a freeze drying cycle on a rational basis such information should be identified.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement